Your Biopharmaceutical Development and Manufacturing Partner

Nanotherapeutics Receives U.S. Department of Defense Contract for Clinical Trial to Treat Dehisced Wounds with NanoDOX® Hydrogel

Business Wire - November 2010

Nanotherapeutics, Inc. announced that it has been awarded a contract by the U.S.Department of Defense (DOD) to support a clinical trial for treating dehisced surgical wounds with the Company's NanoDOX® Hydrogel, a topical doxycycline hydrogel for chronic wounds. Nanotherapeutics is collaborating with Walter Reed Army Medical Center...

Full Article

Copyright 2017 NANOTHERAPEUTICS, INC.  All rights reserved.